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Abstract
AmrZ, a member of the Ribbon-Helix-Helix family of DNA binding proteins, functions as both a transcriptional activator and
repressor of multiple genes encoding Pseudomonas aeruginosa virulence factors. The expression of these virulence factors
leads to chronic and sustained infections associated with worsening prognosis. In this study, we present the X-ray crystal
structure of AmrZ in complex with DNA containing the repressor site, amrZ1. Binding of AmrZ to this site leads to auto-
repression. AmrZ binds this DNA sequence as a dimer-of-dimers, and makes specific base contacts to two half sites,
separated by a five base pair linker region. Analysis of the linker region shows a narrowing of the minor groove, causing
significant distortions. AmrZ binding assays utilizing sequences containing variations in this linker region reveals that
secondary structure of the DNA, conferred by the sequence of this region, is an important determinant in binding affinity.
The results from these experiments allow for the creation of a model where both intrinsic structure of the DNA and specific
nucleotide recognition are absolutely necessary for binding of the protein. We also examined AmrZ binding to the algD
promoter, which results in activation of the alginate exopolysaccharide biosynthetic operon, and found the protein utilizes
different interactions with this site. Finally, we tested the in vivo effects of this differential binding by switching the AmrZ
binding site at algD, where it acts as an activator, for a repressor binding sequence and show that differences in binding
alone do not affect transcriptional regulation.
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Introduction
Pseudomonas aeruginosa is an opportunistic, Gram negative
bacterium that causes a variety of infections, mainly in immune-
challenged patients [1–3]. More notably, chronic lung infection by
P. aeruginosa is the leading cause of death in patients with the
autosomal recessive disorder cystic fibrosis (CF) [4]. The
underlying cause of the severity of these infections is due in part
to the arsenal of virulence factors P. aeruginosa has at its disposal,
including type III secretion systems, production of biofilms,
phospholipase, exotoxin A, motility, and lipopolysaccharide. In
alginate producing strains isolated from CF patients, the
transcription factor AmrZ (Alginate and Motility Regulator Z,
formerly AlgZ) is highly expressed [5]. Our previous work has
shown AmrZ functions as both a transcriptional activator and
repressor of several virulence factors. AmrZ is necessary for
alginate production, via the activation of algD, which is the first
gene in the alginate biosynthetic operon [6]. Reciprocal to this,
AmrZ represses fleQ, which encodes an activator of flagellum
expression [7]. AmrZ is also required for the regulation of genes
responsible for type IV pili localization and twitching motility,
through the interaction with a currently unknown gene target [8].
Finally, AmrZ also represses its own transcription by binding to
two sites on the amrZ promoter, amrZ1 and amrZ2 [9].
The 108 amino acid, 12.3 kD AmrZ protein is a member of the
ribbon-helix-helix (RHH) family of DNA binding proteins, sharing
highest sequence similarity to the Arc and Mnt repressors from
bacteriophage P22 [10]. Sequence analyses predict that there are
over 2300 proteins containing RHH domains found in bacteria,
Archaea, and bacteriophages; however, less than twenty of these
proteins have been studied with structural or biochemical
techniques [11]. Structural information from RHH proteins both
in the presence [12–19] and absence [20–27] of operator DNA,
show that they exist as dimers, formed by a hydrophobic core
created by the two a-helices. The majority of RHH proteins are
transcriptional repressors. AmrZ and Helicobacter pylori NikR are
currently the only characterized RHH proteins known to function
as both transcriptional activators and repressors [23]. DNA
binding by RHH proteins occurs by the insertion of the anti-
parallel b-sheet formed by one b-strand from each monomer into
the major groove of DNA. The interactions between the protein
and the recognition site are very specific, and mutations to either
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negative effect on DNA binding [27,28]. In addition to binding
DNA as a dimer, RHH proteins also assemble as tetramers, which
are stabilized by other domains in the protein, such as occurs with
the C-terminal domain of Mnt [29].
Information from sequence alignments and structural predic-
tions define three regions of the AmrZ protein, an extended N-
terminus spanning residues 1–16, the RHH domain, located from
residues 13–66, and a C-terminal domain from residues 67–108
[30]. Both the extended N-terminus and the C-terminal domain
do not share any sequence similarity to other proteins, and their
exact function has remained an open question. The extended N-
terminus has been hypothesized to play a role in DNA binding,
and is conserved in other AmrZ orthologs of P. putida and P.
syringae [31]. Extended N-termini of other RHH proteins have
been examined, although their functions vary between cofactor
binding, oligomerization and protein-protein interactions, ATP
hydrolysis, in addition to having roles in DNA recognition. The C-
terminal domain of AmrZ is proposed to be involved in protein
oligomerization, which is supported by glutaraldehyde cross
linking assays that show AmrZ forms oligomeric species consistent
with the molecular weight of dimers and tetramers in solution
[30].
Of the genes that are regulated by AmrZ, the specific locations
of the binding sites are only known for two of them. AmrZ
functions as a transcriptional activator at the algD promoter and
binds 282 base pairs upstream of the transcriptional start site.
Additionally, AmrZ acts as a transcriptional repressor of its own
gene and recognizes two sites on the amrZ promoter (amrZ1 and
amrZ2) at positions 293 and 2161. Interestingly, DNA foot-
printing has been performed at each of these three sites, and little
sequence consensus is shared among them [6,9]. Both the algD
operon and amrZ are under the control of the alternative sigma
factor AlgT (AlgU/s
22) [32]. Expression of the algD operon
requires additional factors, including the response regulators AlgB
and AlgR, the nucleosome proteins IHF and AlgP, and the AlgQ
protein, each being necessary, but not sufficient to activate
transcription on their own [5]. To date, only the AmrZ and AlgT
proteins are known to interact with the amrZ promoter region.
Open questions have remained as to the exact strategies
employed by AmrZ to function as both a transcriptional activator
and repressor. It is unclear what specific interactions the protein
makes with both activator and repressor sequences within DNA in
order to carry out these functions. To answer these questions, we
determined the crystal structure of an AmrZ C-terminal
truncation mutant, D42 AmrZ, in complex with an 18 bp
oligonucleotide containing the amrZ1-binding site. This structure
defines the specific recognition site as two half sites separated by a
linker region, and provides evidence that the extended N-terminus
of AmrZ interacts with the DNA in a sequence independent
manner. Site directed mutagenesis experiments of the amrZ1 DNA
reveal that recognition is not only based on the direct readout of
the nucleotide sequences, but also relies on recognition of the
intrinsic shape of the DNA. These data allow for the creation of a
model for transcriptional repression by AmrZ, where a combina-
tion of specific base recognition at two half sites and recognition of
intrinsic DNA structure allow for binding. We also examined the
interaction of AmrZ with the algD-binding site, where AmrZ
binding functions as an activator of alginate biosynthesis. The
results from these assays only identify one AmrZ binding site on
algD and also suggest that the protein may utilize an additional
residue in DNA binding. Finally, we demonstrate that while there
are different protein interactions at the activator and repressor
sequences, these differences alone do not account for the activator
and repressor activity of AmrZ.
Results/Discussion
Structural overview of the D42 AmrZ: 18 bp amrZ1
complex
We determined the structure of a C-terminal truncation mutant
of AmrZ, D42, in complex with an 18 bp oligonucleotide
containing the amrZ1 site to 3.1 A ˚ resolution (Table 1 and
Figure 1A). The D42 variant of AmrZ (residues 1–66) contains the
extended N-terminus and the RHH DNA binding domain, but
has a truncated C-terminal domain. Many C-terminal truncation
variants of AmrZ were used in crystallization experiments, and
D42 was the only AmrZ construct tested that crystallized either in
the presence or absence of DNA. The D42 AmrZ protein was
tested for DNA binding affinity, and compared with the wild type
protein, no reduction in affinity to any of the three known AmrZ
binding sequences (amrZ1/amrZ2/algD) was observed (data not
shown). The structure reveals AmrZ binds the amrZ1 site as a
dimer-of-dimers, and DNA recognition occurs by the interaction
with two half sites on the DNA, separated by five base pairs. There
are no major structural differences between each AmrZ dimer (Ca
RMSD=0.381 A ˚) (Figure 1B). The dimer-dimer interface, which
occludes approximately 290 A ˚ 2 of surface area on each dimer, is
formed by a series of interactions between specific residues located
on the loop connecting a-helix 1 and a-helix 2 on chains B and C
(Figure 1C). The interactions in this region are symmetric, with the
backbone carbonyl of His38 of one protomer forming a hydrogen
bond to Arg40 of the opposing protomer, and the side chain of
His39 forming a salt bridge to Glu51, also across the interface.
The relatively small interface between each dimer, in combination
with evidence that AmrZ forms higher order oligomers in solution
[30], suggests there are likely additional dimer-dimer interactions
mediated by the C-terminal domain of the protein.
The interface between AmrZ monomers to form a dimer is
primarily composed of a-helix 1 and a-helix 2 of each monomer
that come together to form a hydrophobic core. The dimer
Author Summary
The bacterium Pseudomonas aeruginosa causes a variety of
human infections and is the leading cause of death in
patients with cystic fibrosis. The main reason for the
severity of these infections arises from the ability of P.
aeruginosa to express virulence factors that protect it from
the host immune system. Several of these processes are
controlled by a transcription factor called AmrZ, a potential
target for anti-microbial therapeutics. AmrZ is unusual in
that it has the ability to both activate some genes, such as
for alginate biofilm, and repress others, as with flagellum
and itself. Here we determine the three dimensional
structure of AmrZ bound to DNA containing a repressor
sequence. Our structure shows the specific interactions the
protein makes with the DNA for binding and repression. It
also reveals that both the sequence and shape of the DNA
are important for tight association. We next examined the
binding of the protein to DNA containing an activator
sequence and found that it has different interactions.
However, by switching the AmrZ binding site at algD,
where it acts as an activator, for a repressor binding
sequence in P. aeruginosa, we show that differences in
binding alone do not account for transcriptional regula-
tion.
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PLoS Pathogens | www.plospathogens.org 2 April 2012 | Volume 8 | Issue 4 | e1002648Figure 1. Structural overview of AmrZ - amrZ1 complex. (A) The D42 AmrZ protein binds to the 18 bp amrZ1 binding site as a dimer of dimers.
OnedimeriscomposedofchainsA andB(green/cyan), whiletheotherdimeris composedofchainsCandD (magenta/orange).(B)Thesuperpositionof
AmrZ dimers show no major structural differences between them (Ca RMSD=0.381 A ˚). (C) The dimer - dimer interface is created by a network of
hydrogen bonds between the residues in the loop region between a-helix 1 and a-helix 2 of chains A and C. (D) Secondary structure representation of
one AmrZ ribbon-helix-helix monomer. Residues forming hydrogen bonds to DNA are indicated by the purple triangles, while residues forming
hydrophobic interactions to DNA are indicated by purple squares. Residues forming the dimer interface between each monomer are underlined in red,
and the residues which form the dimer-dimer interface are overlined in red. (E) Schematic of both the sequence dependent and sequence independent
interactions between AmrZ and amrZ1. Hydrogen bonding interactions to the DNA are illustrated with a short dashed line, while hydrophobic
interactions are illustrated with a vertical dashed line. Nucleotides involved in sequence specific interactions are represented in orange. The peptide
chain for each residue is labeled in parentheses, and residues that make contacts to more than one nucleotide are notated with an asterisk.
doi:10.1371/journal.ppat.1002648.g001
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underlined residues) and buries approximately 1600 A ˚ 2 of each
monomer. Each AmrZ dimer interacts with the amrZ1 binding site
through sequence dependent interactions (see below), mediated by
the insertion of the anti-parallel b-sheet, formed by dimerization,
into the major groove of DNA. Additionally, a number of
sequence independent interactions to the phosphate backbone are
formed, further supporting the protein-DNA complex (Figure 1E).
The protein - DNA interactions exclude a total surface area of
1469 A ˚ 2 and are symmetric on both halves of the DNA. The one
exception to this is the a-helix 2 N-terminus of chain D, which is
not positioned to interact with the phosphate backbone; however,
this is most likely due to the lack of a 59 phosphate group on the
nucleotide A1, an artifact of chemical DNA synthesis.
Sequence dependent binding by AmrZ
The structure allows us to determine the specific nucleotide
sequence recognized by AmrZ, as well as other factors that
contribute to DNA recognition. The insertion of the anti-parallel
b-sheet from each AmrZ dimer into the major groove of the amrZ1
site provides for the recognition of two half sites, each with the
sequence 59-GGC (Figure 1E, orange bases). Sequence dependent
binding by AmrZ occurs via the interaction of three residues,
Lys18, Val20, and Arg22, with the nucleotides. Lys18 from one
AmrZ monomer is positioned where it can form hydrogen
bonding interactions to the O6 and N7 atoms of the two guanine
nucleotides, G23 and G24 (G4 and G5 on the other half site)
(Figure 2A). The DNA binding b-sheet also orients the residue
Arg22, from the other monomer of the dimer, to form a bidentate
hydrogen bond to both the O6 and N7 atoms of the nucleotide
G12 (G31 on the other half site). This is on the opposite strand of
the two bases with which Lys18 interacts. Bidentate hydrogen
bonding, specifically between arginine residues and guanine
nucleotides, are a major determinant in the selectivity of DNA
bases [33]. Another relevant residue located on the DNA binding
b-sheet is Val20. Interestingly, among other RHH proteins, this
position in the DNA binding b-sheet is generally conserved as a
neutral hydrophilic residue. One other exception to this is the
Neisseria gonorrhoeae FitAB protein in which there is also a valine at
this position [18]. The structure of FitAB in complex with DNA
shows the valine forms a van der Waals interaction with the C5
methyl group of a thymine base. In the AmrZ structure, it appears
that residue Val20 is poised to select for cytosine bases C13 and
C14 (C32 and C33 on other half site) via a hydrophobic
interaction (Figure 2B). Purine nucleotides would not be favorable
in these locations since the N7 atom of the purine base would
interfere with the hydrophobic pocket that is formed by Val20,
while a thymine nucleotide in this position would sterically clash
with the isopropyl side chain of the valine residue.
ToconfirmtherequirementforeachhalfsiteinamrZ1recognition
by AmrZ, a series of mutations were created to the amrZ1 DNA
binding site. Both 1 and 2 nucleotides in each amrZ1 half site were
mutated, and the affinity of WT AmrZ to each of these mutant
sequences was measured using fluorescence anisotropy (Table 2).
Mutating one nucleotide ineach59-GGCAmrZ recognition halfsite
to59-GTCcauseda9.8foldreductioninaffinity,while mutatingtwo
of the nucleotides in each half site to 59-TTC caused a 12.9 fold
reduction in affinity compared to binding to the native amrZ1
sequence. These results confirm the observations from the structure
that sequencedependent recognition occursthrough the interactions
with two half sites, each with the sequence 59-GGC.
We previously evaluated the contribution of Lys18 and Arg22 to
AmrZ activity using in vitro DNA binding assays at amrZ1 and
transcriptional reporter assays to measure amrZ repression [30].
The mutation of Lys18 to an alanine (K18A) resulted in a drastic
reduction in the DNA binding activity, causing a 274-fold increase
in the dissociation constant (Kd), compared to WT AmrZ. When
amrZ was replaced in the P. aeruginosa chromosome with a gene
encoding K18A AmrZ, amrZ derepression was observed, which
was similar in magnitude to that observed in strains harboring null
amrZ alleles. Similar results were obtained for the R22A mutant of
AmrZ, which had a 44-fold increase in Kd compared to WT
AmrZ in vitro, and comparable effects of amrZ transcription in vivo.
When the effects of mutating the valine at position 20 to an
alanine (V20A) were tested in vitro, a 10-fold increase in Kd was
observed. Even with a smaller reduction in DNA binding ability
compared to the K18A and R22A mutants, V20A AmrZ was
unable to repress amrZ transcription in vivo.
The extended N-terminus of AmrZ
We observe electron density for the extended N-terminus
starting at residue 10 on chains A and C. This density is only
Table 1. Crystallographic data collection and refinement
statistics.
Data Collection Statistics
Wavelength (nm) 0.9793
Spacegroup I422
Unit Cell Parameters (a, b, c)(A ˚) 129.5, 129.5, 152.6
(a,b,c)(u) 90, 90, 90
# Complexes/Asymmetric Unit 1
Unique Reflections 22435
Resolution Range (A ˚) 40.00 – 3.1 (3.15 – 3.1)
Mean Redundancy 5.7 (5.8)
Overall Completeness (%) 99.7 (100.0)
Rmerge (%)
(a) 6.9 (54.3)
Mean I/s 29.0 (2.98)
# Se Atoms Found 8
FOM initial 0.41
FOM after density modification 0.65
Model Refinement Statistics
Rwork (%) 26.1
Rfree (%)
(b) 29.5
# Protein Atoms 1522
# DNA Atoms 731
# Water Molecules 7
RMSD Bond Angles (u) 0.006
RMSD Bond Lengths (A ˚) 1.180
Ramachandran Statistics
c
Most Favored Regions 153 (89.0%)
Additionally Allowed Regions 19 (11.0%)
Generously Allowed Regions 0 (0.0%)
Disallowed Regions 0 (0.0%)
aRmerge=(S|I2,I.|)/SI, where I is the observed intensity and ,I. is the
average intensity.
bRfactor=SIFo|2|FcI/S|Fo|. Rfree is calculated with the same equation, but
with 5% of reflections not used in the refinement.
cRamachandran statistics are given as the number of amino acids that lie within
each region, and the percentage is given in parenthesis.
Values in parenthesis are for the outermost resolution shell (3.15 A ˚ – 3.1 A ˚).
doi:10.1371/journal.ppat.1002648.t001
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contacts to the amrZ1 binding site. The lack of electron density of
the extended N-terminus on the side of the AmrZ dimer that does
not contact the DNA suggests that the N-terminus is disordered in
solution, and becomes structured upon DNA binding. Residues
10–17 of the N-terminus form a looped structure, allowing the
amino acids Ser13 and Arg14 in the major groove to interact with
the DNA (Figure 3). This looped structure is supported by the
residue Tyr11, which forms a hydrogen bond to the backbone of
Glu25 from the other monomer in the dimer, and by the head-on
orientation of the carboxyl side chain of Glu25 perpendicular to
the aromatic ring of Tyr11. The side chain of Ser13 forms a
hydrogen bond to a phosphate in the DNA backbone, and also
positions the residue Arg14 into the major groove of the DNA;
however, no contacts between Arg14 and the DNA bases are
observed in the structure. This is consistent with previous studies of
an AmrZ R14A mutant, which has no change in binding affinity
for the amrZ1 DNA when compared to WT protein in vitro, as well
Table 2. AmrZ affinity for amrZ1 binding site mutants.
Binding Site Sequence
a Kd
b (nM) ± SE Fold over WT amrZ1
c
WT amrZ1 GTACTGGCAAAACGCCGGCACG
CATGACCGTTTTGCGGCCGTGC
8.4160.8 1.0
GTC amrZ1 GTACTGT TCAAAACGA ACGGCACG
CATGACA AGTTTTGCT TGCCGTGC
82.768.6 9.8
TTC amrZ1 GTACTT TTCAAAACGA AAGGCACG
CATGAA AAGTTTTGCT TTCCGTGC
109613 12.9
CGCG amrZ1 GTACTGGCC CGCGCGCCGGCACG
CATGACCGG GCGCGCGGCCGTGC
63.467.3 7.5
TTC/GC amrZ1 GTACTT TTCC CGCGCGA AAGGCACG
CATGAA AAGG GCGCGCT TTCCGTGC
20506180 244
TTTT amrZ1 GTACTGGCT TTTTCGCCGGCACG
CATGACCGA AAAAGCGGCCGTGC
41.765.1 5.0
AATT amrZ1 GTACTGGCA AATTCGCCGGCACG
CATGACCGT TTAAGCGGCCGTGC
58.667.5 7.0
ATAT amrZ1 GTACTGGCA ATATCGCCGGCACG
CATGACCGT TATAGCGGCCGTGC
39.164.6 4.7
aThe two AmrZ binding sites on the wild type amrZ1 sequence are represented by the underlined nucleotides. Mutations to the wild type amrZ1 binding site are
notated by the bolded nucleotides in each mutant sequence.
bThe Kd was calculated by fitting the hyperbolic equation for a single ligand binding model with saturation (eq 2) to the data in Figure S2, which were averaged from
four independent experiments.
cFold over (wild type) WT amrZ1 is defined by (Kd of sample)/(Kd of wild type) for each sample.
doi:10.1371/journal.ppat.1002648.t002
Figure 2. AmrZ - amrZ1 interactions. (A) Sequence dependent binding by AmrZ is mediated by the insertion of the DNA binding b-sheet into the
major groove of DNA. AmrZ recognizes two half sites on the DNA, each with the sequence 59-GGC. Lys18 is positioned to form hydrogen bonds to
multiple O6 and N7 atoms on the adjacent guanine nucleotides, G23 and G24 (G4 and G5 on other half site), while Arg22 forms hydrogen bonds to
the O6 and N7 atoms on G12 (G31 on other half site). (B) Electrostatic surface representation of Val20, which is positioned to form hydrophobic
interactions to the two nucleotides C13 and C14 (C32 and C33 on other half site). Electropositive surface potential is denoted in blue, while an
electronegative surface potential is denoted in red. (C) Sequence independent binding by AmrZ is mediated by the N-terminus of a-helix 2, as well as
Arg28 from a-helix 1, which form hydrogen bonding interactions to phosphodiester backbone of multiple nucleotides.
doi:10.1371/journal.ppat.1002648.g002
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contain extended N-termini that contribute to DNA binding. The
Staphylococcus aureus pSK41 plasmid-encoded ArtA protein has a 16
residue N-terminal domain that is necessary for recognition of at
least one of the binding sites of the protein [19]. Additionally, the
seven residue extended N-terminus of the Arc repressor is
disordered in solution, but adopts a tandem-turn structure upon
binding DNA [13], and mutations to the N-terminus result in
decreased binding to operator sites [34]. Although mutations to
the extended N-terminus in AmrZ do not reduce affinity to the
amrZ1 repressor site, AmrZ may act in a manner similar to ArtA,
where the extended N-terminus may provide specificity for DNA
binding at other sites.
Sequence independent binding
There are a number of interactions between AmrZ and the
phosphodiester backbone of the DNA that act to position the
DNA binding b-sheet in the major groove. The majority of these
sequence independent interactions occur with residues located in
the N-terminus of a-helix 2, which points down towards the DNA
backbone (Figure 2C). The positioning of this helix allows the
formation of hydrogen bonding interactions between the side
chains of Ser41 and Ser44, and the backbone amide nitrogens of
Met42 and Asn43 to the phosphate groups of the DNA. This
interaction is further bolstered by the positive dipole of the N-
terminal end of a-helix 2 and the negatively charged phosphate
backbone of the DNA. Another sequence independent interaction
between AmrZ and the DNA occurs via the side chain of Arg28,
from a-helix 1, to the backbone of the DNA. Interestingly, the
location of a-helix 2 also allows the side chain of Asn43 to form
two hydrogen bonding interactions to the backbone amide
nitrogen and carbonyl oxygen of the DNA binding residue,
Arg22, in the opposite monomer. This also helps position Arg22
for interaction with the DNA bases. Sequence independent
interactions formed by the N-terminus of a-helix 2 are one of
the main structural features of RHH proteins [11]. These contacts
are often observed to anchor the protein onto the DNA; however,
in the case of AmrZ, this electrostatic interaction may play an
additional role in recognition of the intrinsic shape of the DNA,
particularly in the linker region.
The linker region between amrZ1 half sites confers
specificity
Analysis of the amrZ1 DNA in the structure reveals a significant
narrowing of the minor groove to 2.8 A ˚ in the A/T rich region
between the two amrZ1 half sites (Figure 4A). In addition to the
narrow minor groove, there is an increase in the width of the
major grooves where AmrZ interacts with each half site, most
likely to accommodate the width of the anti-parallel b-sheet in this
region (Figure 4B). A-tract DNA, as in the amrZ1 site, has specific
properties in that each ApA base pair step exhibits a negative roll,
and bifurcated hydrogen bonds between each adenine and two
Figure 3. The extended N-terminus of AmrZ. The N-terminus of
AmrZ is ordered only when in contact with the DNA (shown as wheat
colored tubes). It forms a looped structure which is stabilized by Glu25
from chain B and Tyr11 from chain A. This region positions the side
chains of two residues, Ser13 and Arg14 in the major groove of DNA.
Ser13 forms hydrogen bonding contacts to the phosphate backbone,
while Arg14 is not positioned to contact any nucleotides. This loop also
interacts with the DNA binding residue Arg22 via the hydrogen bond
between the backbone carbonyl of Ser13 and the eN of the arginine
side chain.
doi:10.1371/journal.ppat.1002648.g003
Figure 4. The DNA linker region between the two AmrZ
binding half sites has a distorted structure. (A) Major and minor
groove widths of the amrZ1 binding site are plotted on the graph with
the corresponding nucleotide sequence above. Values are of inter-
phosphate distance minus their van der Waals surface. Also indicated
are the average major and minor groove widths of 11.7 A ˚, and 5.7 A ˚,
respectively, of B-form DNA (horizontal dashed lines) [68]. The minor
groove in the region between each AmrZ binding half site is narrowed
to 2.8 A ˚ (B) Surface representation of the amrZ1 DNA. The two AmrZ
binding half sites are colored in yellow, while the distorted minor
groove is colored in red. Also shown is the position of the DNA binding
b-sheets on each binding half site.
doi:10.1371/journal.ppat.1002648.g004
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twisting and minor groove narrowing; A-tract DNA is also thought
to be less flexible due to the extra stabilization provided by the
additional bifurcated hydrogen bonds [35]. Based on this we
investigated the region between the two amrZ1 half sites for any
role in AmrZ binding, and whether the binding of AmrZ causes
distortions to the amrZ1 DNA, or if the amrZ1 DNA is intrinsically
distorted, allowing for AmrZ recognition.
To test if the linker region between each AmrZ binding half site
contributes to AmrZ affinity at amrZ1, the native A/T rich linker
sequence 59-AAAAC was mutated to a G/C rich linker region
with the sequence 59-CGCGC, which resulted in a 7.5 fold
reduction in binding (Table 2). It is important to note that this
reduction in binding is not caused by the removal of specific
protein - nucleotide interactions, since there are no contacts
between the AmrZ protein and amrZ1 DNA in this region.
Combining the mutations in the AmrZ binding half site with the
mutations to the linker region (TTC/GC amrZ1) caused a severe
aberration in binding affinity (244-fold reduction). The results
show that binding affinity is regulated by both the sequence
dependent interactions between AmrZ and amrZ1 and the linker
region separating these binding sites.
Additional binding experiments were performed to determine if
the intrinsic structure of the A/T rich linker contributes to binding
affinity. The five base pair linker region on the native amrZ1
binding site was mutated to three sequences, each having their
own unique properties. A sequence with the linker region mutated
to 59-TTTTC resulted in a 5.0-fold reduction in AmrZ binding,
when compared to the WT amrZ1 sequence (Table 2). TpT base
pair steps have the same properties of ApA base pair steps,
including a narrow minor groove and less flexibility [35]. Mutating
the amrZ1 sequence to 59-AATTC caused a 7.0-fold reduction in
affinity when compared to AmrZ binding to the WT amrZ1
sequence (Table 2). Molecular dynamics simulations of the
interactions between the papillomavirus E2 transcription factors
and their binding sites have shown that the 4 nucleotide sequence
AATT has similar minor groove and propeller twist properties to
A-tract DNA [36]. The last amrZ1 mutant binding site tested had a
linker region containing the sequence 59-ATATC, and AmrZ
binding to this site was also altered compared to the WT amrZ1
sequence, causing a 4.7-fold reduction in affinity (Table 2). This
site was designed to test if flexibility in the linker region allowed
AmrZ to distort the DNA and form a complex. The TpA step in
this sequence permits variations in roll, twist and slide due to poor
stacking between these base pairs, and DNA containing these steps
contain wider minor grooves, caused by the steric clashing of cross
strand adenines [37]. It should be noted that the properties
described for these sequences are average parameters derived from
structures and that individual structures show a range of
properties, specifically minor groove width [38]. Although AmrZ
had reduced affinity for each of these three sequences, the most
dramatic effect was mutation of the linker region to 59-CGCGC.
Binding of AmrZ to the sequence 59-ATATC was reduced
suggesting that A/T content of the sequence, which is usually
thought to impart flexibility to DNA, was not the main contributor
to AmrZ specificity. AmrZ binding to the two sequences harboring
mutant linker regions with similar properties to the A-tract
sequence (59-TTTTC and 59-AATTC) was decreased, suggesting
that there are properties unique to the 59-AAAAC linker sequence
in the native amrZ1 binding site that allow for binding specificity.
Taken together, these data allow us to propose that binding
specificity is directed by intrinsic distortions to the DNA, rather
than the flexibility conferred by the A/T rich sequence
composition. Recognizing a physical feature of the DNA rather
than a specific sequence introduces degeneracy in the recognition
sequence that would influence the number of potential recognition
sites for AmrZ. We queried the P. aeruginosa PAO1 genome [31] for
the number of binding sites with the exact amrZ1 repressor
sequence and found 5 sites. If we allow the A/T linker region to be
degenerate, the number of potential binding sites increases to 77.
Further biological studies will be required to determine how many
of these sites function as actual regulators.
Narrowed minor grooves of DNA have a strong correlation
between the width and increased electronegative potential of the
minor groove [38]. There are many examples of transcription
factors that recognize local distortions of the minor groove in
addition to sequence specific recognition in both prokaryotic and
eukaryotic organisms. The Listeria monocytogenes helix-turn-helix
(HTH) transcription factor MogR recognizes two half sites on the
flaA operator site [39]. The minor groove between the two half
sites is distorted, and contributes to MogR specificity for this site.
Another example is the myocyte enhancer factor-2 (MEF2), a
member of the MADS-box superfamily, which recognizes a
narrowed minor groove on the consensus sequence to bind and
activate transcription [40]. These two examples, in addition to
others, use positively charged residues, specifically arginine, to
recognize and form contacts with the enhanced electronegative
potential of the narrow minor groove [38]. However, there are
examples of proteins similar to AmrZ that recognize minor groove
shape, but do not make any contacts to the minor groove. The
classical example is the bacteriophage 434 repressor recognition of
six binding sites on the two operator regions, OR and OL, which is
greatly modulated by the sequence composition of the central
region of these sites [41]. These variations in binding affinities
have been shown to be biologically important in directing the
lysogenic or lytic fate of bacteriophage 434 [42]. Although the 434
repressor positions an arginine residue near the minor groove,
there are no specific contacts by the protein to this region, and
mutational analysis shows that this arginine does not contribute to
binding affinity [41]. Recently, recognition of the intrinsic
structure of narrowed minor grooves has been studied with the
DNA bending protein Fis, which is responsible for the compaction
of bacterial DNA [43]. An A/T rich (59-AATTT) narrowed minor
groove, located between two Fis binding sites is compressed,
allowing for the insertion of two HTH domains into the adjacent
major grooves of DNA. Mutations to this narrow minor groove
sequence cause changes in binding, with the biggest change
occurring by mutating the sequence to a G/C rich sequence (59-
GGCGC). Narrowed minor grooves between binding half sites
have been observed in other RHH protein - DNA structures. In
the structure of Arc in complex with DNA, the minor groove
between half sites is narrowed to 1.2 A ˚, and the sequence in this
region has the sequence 59-GTGCT [13]. Likewise, in the
Streptococcus sp. CopG-DNA structure the minor groove is
narrowed to 1.9 A ˚ and has the sequence 59-TTGAG [14]. The
DNA in complex with the inc18 plasmid encoded omega protein
has a minor groove width of 2.7 A ˚, and the A/T rich sequence 59-
AAAT. Also, due to a fortuitous packing arrangement in the
crystal, both bound and free DNA were observed, with the free
DNA having similar secondary structure as the omega bound
DNA [16]. For each of these proteins, the contributions of the
linker region between the two half sites to binding have not been
determined.
Alterations in the sequence specific half sites, the linker region,
or both can modulate affinity for AmrZ to amrZ1; however, the
exact mechanism by which AmrZ recognizes the distorted
structure of the minor groove remains enigmatic. In the
D42AmrZ-amrZ1 structure (Figure 1A), there are no positively
DNA Recognition by the Transcription Factor AmrZ
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N-terminus of AmrZ contains an arginine at position 2 which
might make these contacts; however, in vitro DNA binding assays
performed with various N-terminal truncation mutants of AmrZ
showed no decrease in binding to amrZ1 [30]. The phosphate
backbone on either side of the narrow minor groove of amrZ1 is
contacted on each side by the N-terminus of a-helix 2 from chains
A and C (Figure 1A, 2C). This attraction is most likely enhanced
due to the positive dipole formed by the N-terminus of the a-helix
and the increased electronegative potential of the narrowed minor
groove.
AmrZ binding to the activator site, algD
In addition to functioning as a repressor when bound to amrZ1,
AmrZ binding to the algD site is necessary for the activation of
genes responsible for alginate biosynthesis. Interestingly, there are
significant divergences between the activator and repressor
sequences, and AmrZ affinity to the algD binding site is
approximately 24 fold reduced compared to the amrZ1 binding
site (Tables 2 & 3). Using the information from the AmrZ
interaction with the repressor amrZ1 binding site, we asked if we
could predict how AmrZ interacts with the binding site on the algD
promoter (Figure S1). We set out to determine the features of the
algD sequence necessary for AmrZ recognition and activation. By
aligning the left half AmrZ binding site on amrZ1 (59-GGC) to the
algD sequence (positions 5–7), it became apparent that there is no
similar right half binding site on algD, and additionally, the
sequence of the linker region is also different (Figure 5A). In order
to probe the interaction between AmrZ and algD, multiple single
nucleotide mutations of the algD site were created, and binding
affinity of AmrZ to each of the mutant algD sequences was
measured with fluorescence anisotropy.
Through mutagenesis of nucleotides in the proposed left half
binding site in algD, we show that AmrZ recognizes the sequence
59-GGC at this site. The guanine nucleotides at positions 5 and 6
on one strand of the algD binding site and positions 7 and 8 on the
other strand (Figure 5A) were mutated to thymine bases, and the
binding affinity of AmrZ to each of these mutant sequences was
measured (Table 3, Figure 5B). The mutation to position 5
resulted in a slight increase to AmrZ affinity, while mutations to
positions 6, 7, and 8 each resulted in significant reductions in
Figure 5. AmrZ binding to the algD activator site. (A) Alignment
of the amrZ1 and algD DNA sequences that have been derived from
previous footprinting experiments [6,9]. The two binding half sites on
the amrZ1 sequence are boxed, while nucleotides that were mutated in
the algD sequence are shown in red. (B) Results from the scanning
mutagenesis of the algD site (Table 3). Only mutations of guanine
nucleotides at positions 6 (forward strand), and 7 and 8 (reverse strand)
resulted in a noticeable decrease in binding affinity of AmrZ compared
to the WT algD sequence. Mutations to the right side binding half site
resulted in no major decrease in binding affinity of AmrZ. Percent
affinity was calculated by dividing the Kd for the WT algD binding site
by the Kd for each mutant binding site.
doi:10.1371/journal.ppat.1002648.g005
Table 3. AmrZ affinity for algD binding site mutants.
Binding Site Sequence
a Kd
b (nM) ± SE Fold over WT algD
c
WT algD CATTGGCCATTACCAGCCTCCC
GTAACCGGTAATGGTCGGAGGG
198614 1.0
m5 algD CATTT TGCCATTACCAGCCTCCC
GTAAA ACGGTAATGGTCGGAGGG
164617 0.8
m6 algD CATTGT TCCATTACCAGCCTCCC
GTAACA AGGTAATGGTCGGAGGG
723637 3.7
m7 algD CATTGGA ACATTACCAGCCTCCC
GTAACCT TGTAATGGTCGGAGGG
530652 2.7
m8 algD CATTGGCA AATTACCAGCCTCCC
GTAACCGT TTAATGGTCGGAGGG
365630 1.8
m13 algD CATTGGCCATTAA ACAGCCTCCC
GTAACCGGTAATT TGTCGGAGGG
256620 1.3
m14 algD CATTGGCCATTACA AAGCCTCCC
GTAACCGGTAATGT TTCGGAGGG
216617 1.1
m16 algD CATTGGCCATTACCAT TCCTCCC
GTAACCGGTAATGGTA AGGAGGG
203617 1.0
m17 algD CATTGGCCATTACCAGA ACTCCC
GTAACCGGTAATGGTCT TGAGGG
212619 1.1
aMutations to the wild type algD binding site are notated by the bolded nucleotides in each mutant sequence.
bThe Kd was calculated by fitting the hyperbolic equation for a single ligand binding model with saturation (eq 2) to the data in Figure S3, which were averaged from
four independent experiments.
cFold over (wild type) WT algD is defined by (Kd of sample)/(Kd of wild type) for each sample.
doi:10.1371/journal.ppat.1002648.t003
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right half of the algD binding site, guanine bases at position 16 on
one strand, and positions 13, 14, and 17 on the opposite strand of
algD were mutated to thymine residues. No significant differences
in binding affinity to these sequences are observed (Table 3,
Figure 5B), suggesting that AmrZ interacts with this half site in a
different manner than what is observed at amrZ1.
Our previous binding experiments show the same residues,
Lys18, Val20, and Arg22 are involved in the sequence dependent
interactions with algD [30]. In addition, we found that Arg14 is
also necessary for binding, with the R14A mutant of AmrZ
exhibiting a 5 fold reduction in binding affinity at algD. This
arginine residue is also required for transcriptional activation of
algD, where R14A AmrZ only retains 3% of WT activity in vivo.
From the AmrZ - amrZ1 structure, the extended N-terminus forms
a looped structure which positions Arg14 into the major groove of
DNA (Figure 3); however, no specific contacts between this residue
and the amrZ1 DNA are observed, and mutations of this residue
have no effects on in vitro and in vivo activity at the repressor site.
algD promoter swapping
The differences we observe in interactions of AmrZ with the
activator algD binding sequence versus the repressor amrZ1 binding
sequence led us to ask if these different binding modes alone could
account for activation or repression activity. To test this hypothesis
we switched the AmrZ binding site in the algD promoter (activator)
with the amrZ1 binding site (repressor) and introduced this variant
into an algD::lacZ transcriptional fusion, which was stably
integrated into the genome of the mucoid P. aeruginosa strain
FRD1 (FRD1 palgDamrZ1-lacZ). The position and length of the
switched binding site were the same as in the native algD promoter.
With this construct we measured relative activation at algD with a
b-galactosidase activity assay compared to an algD::lacZ transcrip-
tional fusion containing the wild type algD AmrZ binding site
(FRD1 palgD-lacZ). The results of this experiment (Table 4) reveal
activation of algD remains unchanged when the amrZ1 binding site
replaced the native site. Cell lysates from the FRD1 palgDamrZ1-lacZ
strain had 527.7 units of b-galactosidase activity compared to
536.1 units for FRD1 palgD-lacZ. Expression of both palgD-lacZ
and palgDamrZ1-lacZ were significantly reduced in amrZ mutant P.
aeruginosa strains (Table 4), indicating that the reporter fusion
faithfully reproduced what has been observed previously regarding
AmrZ activation of algD [5,10,30]. The activation of algD with the
amrZ1 repressor site at its promoter supports a model in which
AmrZ binding alone does not regulate activation or repression of
transcription, but rather interactions of AmrZ with other
regulators at the amrZ and algD promoters likely contribute to
repression or activation, respectively. This is consistent with the
previous evidence that the AlgB, AlgR, IHF, and CysB regulators
are known to bind on the algD promoter and are necessary for
activation [44–48], suggesting a possible interaction of AmrZ with
one of these proteins. To date, no other regulators have been
identified to bind the amrZ promoter; however, it is possible one of
these same regulators may also interact with AmrZ there as well.
An additional determinant likely dictating activation versus
repression is the position of the AmrZ binding site relative to the
start of transcription, which differs for algD (2282) and amrZ1
(293).
Conclusions
AmrZ functions as both a transcriptional activator and repressor
of P. aeruginosa virulence genes. We have determined the structure
of D42 AmrZ in complex with an 18 base pair oligonucleotide
containing the amrZ1 binding site. AmrZ binding to this site results
in the repression of amrZ transcription. By combining structural
and biochemical data, we developed a model for AmrZ
recognition at amrZ1. Using the suggested terminology from the
recent review by Rohs et al. [49], the protein-DNA specificity of
AmrZ can be classified by major groove base readout through
protein residues in the b-sheet with two GGC half sites in the
DNA. This is combined with local shape readout utilizing minor
groove distortions in the linker region between the half sites. We
also probed the interaction of AmrZ with another biologically
important binding site algD, which leads to the activation of
alginate biosynthesis. In contrast, we observed stark differences in
the physical interactions that AmrZ makes with the algD sequence
that suggest the protein likely utilizes a different mode of
recognition at this site. AmrZ binds the algD sequence with lower
affinity, and mutagenesis of the algD sequence shows that only one
half site contributes to AmrZ binding. However, these differences
in protein binding at the promoter sequences are alone not
sufficient to account for the activator or repressor activity of
AmrZ, and likely the position of AmrZ binding at the promoter
and/or protein interactions with other regulators are also
necessary for biological function.
Materials and Methods
Molecular cloning, expression and purification of WT and
D42 P. aeruginosa AmrZ
The gene encoding WT AmrZ was PCR amplified from the P.
aeruginosa strain PAO1 with the primers amrZ_F (59-CGCCAT-
CACATATGCGCCCACTGAAACAGGC) and amrZ_wt_R (59-
CGCCATCAGGATCCTCAGGCCTGGGCCAGCTC). The
resulting gene product was then inserted into a modified pET19
expression vector (Novagen) which encodes an N-terminal poly-
Histidine tag, followed by a Rhinovirus 3C protease cleavage site,
which permits the removal of the affinity tag (PreScission Protease,
GE Healthcare). The pET19-amrZ vector was transformed into E.
coli C41(DE3) cells for expression. One liter of LB-Broth (Luria-
Bertani) supplemented with 50 mg/ml of ampicillin was inoculated
with 10 ml of an overnight culture of the C41 cells containing the
pET19-amrZ vector. The cells were grown at 37uCt oa n
OD600=0.5, and induced with 1 mM isopropyl b-D-thiogalacto-
pyranoside (IPTG) at 16uC for 20 hours. Prior to induction with
IPTG, cells were rapidly cooled on ice to 20uC to bring the
temperature of the culture close to the induction temperature.
Induction of the cells at low temperature was necessary for protein
solubility during overexpression. Cells were harvested by centri-
fugation, resuspended in lysis buffer (100 mM KH2PO4 pH 7.5,
500 mM NaCl, 10% glycerol, 4 M urea), and lysed using an
EmulsiFlex C-5 cell homogenizer (Avestin). Cell debris was
Table 4. Transcriptional activation of algD containing amrZ1-
repressor binding sequence.
P. aeruginosa Genotype Units b-galactosidase
FRD1 palgD-lacZ 536.1+/220.5
FRD1 lacZ 73.9+/241.3
FRD1 palgDamrZ-lacZ 527.7+/211.6
FRD1 DamrZ palgD-lacZ 114.7+/215.3
FRD1 DamrZ lacZ 72.2+/234.3
FRD1 DamrZ palgDamrZ-lacZ 151.3+/224.4
doi:10.1371/journal.ppat.1002648.t004
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10 ml Ni-NTA (Qiagen) column equilibrated with lysis buffer.
This column was washed with 20 column volumes of wash buffer 1
(100 mM KH2PO4 pH 7.5, 500 mM NaCl, 10% glycerol, 35 mM
imidazole, 3 M urea), followed by 10 column volumes of wash
buffer 2 (100 mM KH2PO4 pH 7.5, 500 mM NaCl, 10%
glycerol, 50 mM imidazole, 2 M urea). Bound AmrZ was eluted
with elution buffer (100 mM KH2PO4 pH 7.5, 500 mM NaCl,
10% glycerol, 500 mM imidazole, 1 M urea), treated with
PreScission Protease according to the manufacturer’s directions,
and dialyzed over night at 4uC against 100 mM Bis-Tris pH 5.5,
100 mM NaCl, 5% glycerol, 2 mM dithiothreitol (DTT), and
0.5 mM EDTA. The partial denaturing conditions introduced by
the 4 M urea were necessary for protein solubility and affinity to
the Ni-NTA column, and no change in secondary structure or
DNA binding affinity was observed compared to protein purified
without urea present. AmrZ was then passed over a MonoS cation
exchange column, and eluted with a 0.1 M–1 M gradient of NaCl.
Purity of the peak fractions was verified by SDS-PAGE, and
fractions containing pure WT AmrZ were pooled. For crystalli-
zation experiments, AmrZ was dialyzed against 100 mM Bis-Tris
pH 5.5, 100 mM NaCl, 2% glycerol, while for DNA binding
assays, AmrZ was dialyzed against a buffer containing 100 mM
Bis-Tris pH 6.5, 150 mM NaCl, 5% glycerol. WT AmrZ was then
concentrated to 20 mg/ml for crystallization experiments, or
1 mg/ml for DNA binding assays, aliquoted, flash frozen in liquid
nitrogen, and stored at 280uC. Concentration of WT AmrZ was
measured using the BCA assay (Thermo Scientific) using a
standard curve of lysozyme as a reference.
The D42 C-terminal truncation mutant of AmrZ was amplified
from the P. aeruginosa strain PAO1 using the primers amrZ_F and
amrZ_D42_R (59-CGCCATCAGGATCCTCAAACACCGA-
GATTGTCTTG). Expression and purification of this protein
was carried out using the procedures outlined for WT AmrZ.
Crystallization of D42 AmrZ - amrZ1 complex
Crystallization trials of AmrZ were carried out by screening
multiple AmrZ C-terminal deletion constructs against a library of
double stranded DNA oligonucleotides containing the amrZ1
binding site (Integrated DNA Technologies). Initial crystals were
obtained only with the D42 AmrZ C-terminal truncation and an
18 bp oligonucleotide in a condition containing 6% PEG 8 K,
0.1 M MES pH 6.0, 0.1 M CaCl2, 0.1 M NaCl. For experimental
phasing, selenomethionine (Se-Met) derivatized D42 AmrZ was
prepared using published methods [50]. Purification of this protein
was performed using the methods described above, with the only
exception being the addition of 5 mM DTT in the final dialysis
buffer. Crystals of the Se-Met D42 AmrZ - 18 bp amrZ1 complex
were obtained by mixing the protein and DNA in a 1:1.5 molar
ratio (810 mM AmrZ: 607.5 mM amrZ1) in the presence of 50 mM
MgSO4. This complex was crystallized by the hanging drop vapor
diffusion method at 25uC at a 1:1 ratio with reservoir solution
containing 3% PEG8K, 0.1 M MES pH 6.0, 0.15 M NaCl, and
2 mM TCEP pH 8.0. Crystals grew within 2–3 weeks and were
soaked in a solution containing 20% 2-methyl-1,3 propanediol for
cryo-protection before being frozen in liquid nitrogen for data
collection.
Data collection and refinement of the D42 AmrZ - amrZ1
structure
Diffraction data for crystals containing the D42 AmrZ: 18 bp
amrZ1 complex were collected on beamline X25 at the National
Synchrotron Light Source (NSLS), Brookhaven National Labs.
The dataset was collected at the selenium peak, with an X-ray
wavelength of 0.9793 nm. Indexing, integration and scaling of the
data were performed using HKL2000 program suite [51]. Phasing
of the structure was performed using SAD methods with the
program SOLVE [52], and density modification was performed
using RESOLVE [53]. Manual model building was performed in
Coot [54], and refinement was carried out using the programs
REFMAC5 [55] within the CCP4 program suite [56], and CNS
[57]. Data collection and refinement statistics are found in Table 1.
The atomic coordinates and structure factors have been deposited
in the Protein Data Bank under the PDB id 3QOQ.
DNA binding measurements
Binding affinity of the various amrZ1 and algD binding site
mutants were performed using fluorescence anisotropy as
previously described [30,58]. In brief, increasing concentrations
of WT AmrZ were incubated in a reaction (25 ml) containing
1 nM 22-mer 59-6-carboxy-fluorescein (6-FAM) labeled DNA
oligonucleotide (IDT) containing either the amrZ1 or the algD
sequences, 100 nM nonspecific DNA of random sequence,
100 mg/ml bovine serum albumin (BSA), 100 mM Bis-Tris
pH 6.5, 150 mM NaCl, and 5% glycerol. DNA concentrations
were kept 1 nM (,,Kd) to ensure equilibrium measurements of
binding constants. Anisotropy measurements were recorded at
25uC on a Safire2 microplate reader with a fluorescence
polarization module (Tecan Group, Ltd.), using an excitation
wavelength of 470 nm and an emission wavelength of 525 nm.
Anisotropy data were scaled and normalized using Equation 1
below:
A~(Aobs{A0)=Amax ð1Þ
In this equation, Aobs is the measured anisotropy value for each
AmrZ concentration, A0 is the anisotropy of the unbound DNA,
and Amax is the maximum anisotropy observed in each
experiment. The dissociation constant (Kd) was calculated by
fitting the data to the equation for a single state binding model
(Equation 2).
A~Amax½P =(Kdz½P ) ð2Þ
Fitting of the data to Equation 2 was performed using SigmaPlot.
Raw data and fits for AmrZ binding to each DNA sequence can be
found in Figures S2 and S3, with the results from these
experiments being presented in Tables 2 and 3. Results presented
are the averages of four independent experiments.
Calculation of protein and DNA parameters
The program CURVES+ [59] was used to measure the major
and minor groove widths of the amrZ1 DNA. The buried surface
areas formed by protein-DNA interactions and by protein-protein
interactions were measured using the programs AREAIMOL in
the CCP4 suite [56] and PDBsum [60], respectively. Ramachan-
dran statistics found in Table 1 were calculated with PDBsum
[60]. Electrostatic surface representations of the protein and DNA
were created by first generating a PQR file, which contains charge
and radius information for each atom, with the program
PDB2PQR [61], followed by visualization of the electrostatic
surface using the APBS program [62]. All figures of structural
representations were prepared using the program PyMol [63].
amrZ promoter switching
The AmrZ binding site (ABS) (CCATTGGCCATTAC-
CAGCCTCCC) in the algD promoter was replaced by the
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GC) from the amrZ promoter by site-directed mutagenesis [64].
Mutagenesis was achieved by primers algD74 (GCGTGC-
CGGCGTTTTGCCAGTACATTACGCCGGAGATGGCAT-
TTC) and algD75 (GTACTGGCAAAACGCCGGCACGCGC-
CATTACATGCAAATTACGATTGC), together with flanking
primers algD65 (CCCCAAGCTTCTCTTTCGGCACGCCG-
AC) and algD66 (CCGGGATCCCCGACATAGCCCAAAC-
CAAAG). PCR products of algD65/algD74 and algD66/algD75
were denatured and hybridized. The products were used as the
template for the second PCR, with primers algD65 and algD66.
With HindIII and BamHI sticky ends, the final PCR product was
cloned into HindIII and BamHI double digested mini-CTX-lacZ
transcriptional fusion vector [65], resulting in a new plasmid
pBX8, which harbors modified algD::lacZ transcriptional fusion
(palgDamrZ1-lacZ). The sequence of the palgDamrZ1-lacZ promoter was
verified by PCR and sequencing.
Construction of transcriptional fusion in P. aeruginosa
chromosome
The plasmid pBX8 was transferred into P. aeruginosa FRD1
using E. coli strain SM10. The modified palgDamrZ1-lacZ transcrip-
tional fusion was integrated at the attB site within the chromosome
of FRD1 and FRD1 DamrZ [30], and the unnecessary portion of
the fragment was removed by pFLP2 [66], resulting in FRD1
palgDamrZ1-lacZ or FRD1 DamrZ palgDamrZ1-lacZ, respectively.
b-galactosidase assays
P. aeruginosa in mid-log phase were pelleted and washed with Z-
buffer (110 mM Na2HPO4, 45 mM NaH2PO4, 10 mM KCl,
2 mM MgSO4, pH7.0). Cells were lysed through three rounds of
fast freezing at 280uC then thawing at 37uC, followed by mild
sonication. Samples were centrifuged at 18 k6 g and 4uC for
10 min at 21,0006 g. The supernatants were analyzed for b-
galactosidase activity by mixing 10 ml of a sample supernatant with
80 ml of Z-buffer. To start the reaction 20 ml of 4 mg/ml
orthonitrophenol was added. The color change in the reaction
was monitored with time and reactions were stopped by addition
of 40 ml1MN a 2CO3 for reading. Wild type FRD1 palgD::lacZ
transcriptional fusion was the positive control, and FRD1 lacZ with
no promoter acted as the negative control. The absorbance at both
420 nm and 550 nm of each reaction solution was read in a
Molecular Devices M5 microplate reader. Miller Units were
calculated from different strains as outlined [67].
Supporting Information
Figure S1 Sequences of known AmrZ binding sites. The
two known AmrZ binding sites on the amrZ promoter leading to
amrZ repression (amrZ1 and amrZ2), and the one known binding
site on the algD promoter, leading to activation of the alginate
biosynthetic pathway are shown here. These sites have been
determined experimentally through DNA footprinting experi-
ments [6,9], and share little consensus. The sequences are aligned
based on the region of highest similarity. In the consensus above
the sequences, uppercase nucleotides represent bases that are
present in all three sequences, while lowercase nucleotides
represent bases that are present in only two of the sequences.
(TIF)
Figure S2 AmrZ - amrZ1 binding data. Fluorescence
anisotropy was utilized to calculate the binding affinity for AmrZ
to multiple sequences harboring mutations in the amrZ1 binding
site. Each data point is an average from four independent
experiments, and the error bars are calculated from the standard
deviation. Data was processed as described in the Materials and
Methods section, and results from these data are shown in Table 2.
(A) AmrZ: WTamrZ1 (B) AmrZ: GTCamrZ1 (C) AmrZ: TTCamrZ1
(D) AmrZ: CGCGamrZ1 (E) AmrZ: TTC/GCamrZ1 (F) AmrZ:
ATATamrZ1 (G) AmrZ: TTTTamrZ1 (H) AmrZ: AATTamrZ1.
(TIF)
Figure S3 AmrZ - algD binding data. To determine the
AmrZ binding site on the algD promoter, multiple mutations to the
algD DNA sequence were created and binding affinities between
AmrZ and these sequences were determined using fluorescence
anisotropy. Each data point is an average from four independent
experiments, and the error bars are calculated from the standard
deviation. Data from these experiments were processed as
described in the Materials and Methods section, and results are
shown in Table 3. (A) AmrZ: WTalgD (B) AmrZ: m5algD (C)
AmrZ: m6algD (D) AmrZ: m7algD (E) AmrZ: m8algD (F) AmrZ:
m13algD (G) AmrZ: m14algD (H) AmrZ: m16algD (I) AmrZ:
m17algD.
(TIF)
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